Analysed IMMUNEERING CORP - CLASS A (IMRX:NASDAQ) News Sources
Immuneering to Present Molecular Data at 2026 AACR Annual Meeting from Atebimetinib-Treated Patients, Highlighting Mechanism Designed to Improve Durability and Survival
17-03-2026
yahoo.com
Immuneering to Present at the 25th Annual Needham Virtual Healthcare Conference
06-04-2026
yahoo.com
Immuneering CEO Touts 64% 12-Month Survival in Pancreatic Cancer; Phase 3 Launch Nears
14-04-2026
marketbeat.com
Immuneering Presents Genetic Data at AACR Annual Meeting Demonstrating Mechanism to Improve Durability and Survival, Supporting Use of Atebimetinib in First-Line Pancreatic Cancer and Beyond
20-04-2026
yahoo.com
Immuneering to Present New Survival Data from First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP in an Oral Presentation at the 2026 ASCO Annual Meeting
21-04-2026
yahoo.com
Immuneering Reports First Quarter 2026 Financial Results and Provides Business Updates
15-05-2026
yahoo.com
Immuneering Reports 17.3 Months Median Overall Survival in First-Line Metastatic Pancreatic Cancer Patients Treated with Atebimetinib Plus Chemotherapy
21-05-2026
yahoo.com
Immuneering Presents Compelling 17.3-Month Median Overall Survival and Favorable Tolerability with Atebimetinib + Chemotherapy in First-Line Pancreatic Cancer Patients at ASCO
01-06-2026
yahoo.com
What is the current price of IMMUNEERING CORP - CLASS A (IMRX:NASDAQ)?
The current price of IMMUNEERING CORP - CLASS A (IMRX:NASDAQ) is $4.55.
IMMUNEERING CORP - CLASS A (IMRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of IMMUNEERING CORP - CLASS A (IMRX:NASDAQ) since the previous trading day is $0.27.
IMMUNEERING CORP - CLASS A (IMRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of IMMUNEERING CORP - CLASS A (IMRX:NASDAQ) since the previous trading day is 6.3084%.
What is the most recent average sentiment score for IMMUNEERING CORP - CLASS A (IMRX:NASDAQ)?
The most recent average sentiment score for IMMUNEERING CORP - CLASS A (IMRX:NASDAQ) is 69 out of 100.
What is the most recent average sentiment for IMMUNEERING CORP - CLASS A (IMRX:NASDAQ)?
The most recent sentiment for IMMUNEERING CORP - CLASS A (IMRX:NASDAQ) is .
SEC-8K** Filing Available For IMMUNEERING CORP - CLASS A (IMRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.